Community-Aquired Pneumonia

個数:

Community-Aquired Pneumonia

  • 提携先の海外書籍取次会社に在庫がございます。通常2週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 製本 Hardcover:ハードカバー版/ページ数 930 p.
  • 言語 ENG
  • 商品コード 9780306464324
  • DDC分類 616.241

Full Description


Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly from one geographic area to the next, and the scientific basis for many of our management strategies for pneumonia is weak to nonexistent. There are over 100 microbial agents that can cause pneumonia and many of these, especially Streptococcus pneumoniae, Group A streptococcus, and Staphylococcus aureus, are in a state of flux in terms of changing antimicrobial resistance. This book is designed to provide new information about pneumonia and identify critical research questions that will come to the fore as we enter the 21st century.

Table of Contents

  The Captain of the Men of Death: The History     1  (12)
of Pneumonia
Jock Murray
The Earliest Records 1 (1)
The Early Descriptions 1 (2)
The Clinical Examination of Pneumonia 3 (1)
To Bleed or Not to Bleed? 4 (1)
Pneumonia in the American Civil War 5 (1)
Pneumonia in Hospital and in General 5 (1)
Practice
The Advent of Serotherapy 6 (1)
Osler's Approach to the Captain of the Men 6 (1)
of Death
World War I and the Influenza Pandemic 7 (1)
After the War 8 (1)
The Development of Penicillin 9 (1)
The Development of Sulfa Drugs 9 (1)
The Massachusetts Pneumonia Study and 10 (1)
Service
Mycoplasma Pneumonia (Primary Atypical 10 (1)
Pneumonia)
Recent Events in Pneumonia 10 (1)
References 11 (2)
Epidemiology of Community-Acquired Pneumonia 13 (16)
Irma Koivula
Introduction 13 (1)
Incidence of Community-Acquired Pneumonia 14 (5)
Risk Factors for Pneumonia in the Elderly 19 (3)
Death from Pneumonia 22 (1)
References 23 (6)
Community-Acquired Pneumonia: Clinical 29 (6)
Features and Outcomes
Thomas J. Marrie
Introduction 29 (1)
Symptoms at Presentation 29 (1)
Accuracy of Clinical Findings for 30 (1)
Diagnosing CAP
Comorbid Illnesses in Patients with CAP Who 31 (1)
Require Admission to Hospitals
Outcomes 32 (1)
Complications 32 (1)
Resolution of Symptoms 32 (1)
Pneumonia Syndromes 32 (1)
Cost of Treating Community-Acquired 33 (1)
Pneumonia
Summary 33 (1)
References 33 (2)
Laboratory Diagnosis of Community-Acquired 35 (10)
Pneumonia
Ross J. Davidson
Kelly S. MacDonald
Introduction 35 (1)
Sputum Gram's Stain and Culture 35 (2)
Blood Cultures 37 (1)
Bronchoscopic Methods 37 (2)
Antigen Detection Methods 39 (1)
Serology 40 (1)
References 41 (4)
PCR Techniques in the Diagnosis of Pneumonia 45 (10)
Due to Chlamydia pneumoniae, Legionella
Species, and Mycoplasma pneumoniae
Barry S. Fields
Introduction 45 (1)
Chlamydia pneumoniae 45 (1)
Legionellae and Legionella pneumophila, 46 (2)
Mycoplasma pneumoniae
PCR-Based Epidemiology of 48 (4)
Community-Acquired Pneumonia
Conclusions 52 (1)
References 52 (3)
Imaging Community-Acquired Pneumonia 55 (46)
Gerry Schaller
Mark Logan
Introduction 55 (1)
The Role of the Chest Radiograph 55 (1)
Technical Considerations 56 (1)
Systematic Approach to the Chest Radiograph 57 (1)
Radiographic Appearance of Pneumonia 58 (9)
Pneumonia Pattern Recognition 67 (3)
Specific Pneumonia Patterns 70 (7)
Location of the Pneumonia 77 (1)
Lymphadenopathy 78 (2)
Specific Etiologies 80 (10)
Specific Complications of Pneumonia 90 (3)
Additional Imaging--Chest Radiographs 93 (3)
Additional Imaging--Other Modalities 96 (3)
References 99 (2)
The Pathology of Community-Acquired Pneumonia 101(30)
Claudia Molina
David H. Walker
Lobar Pneumonia 101(1)
Bronchopneumonia 102(1)
Interstitial Pneumonia 102(1)
Mixed Patterns 103(1)
Miliary Pattern 103(1)
The Pathology of Specific Agents 103(19)
Chemical Pneumonia 122(2)
References 124(7)
Etiology of Community-Acquired Pneumonia 131(12)
Thomas J. Marrie
Introduction 131(1)
Overview of the Etiology of 132(1)
Community-Acquired Pneumonia
Bacteremic Community-Acquired Pneumonia 132(2)
Etiology of Community-Acquired Pneumonia 134(1)
Treated on an Ambulatory Basis
Etiology of Community-Acquired Pneumonia 134(1)
among Patients Requiring Admission to
Hospital
Etiology of Nursing Home-Acquired Pneumonia 134(5)
Etiology of Community-Acquired Pneumonia 139(1)
among Patients Who Require Admission to an
Intensive Care Unit
Etiology of Community-Acquired Pneumonia in 139(1)
Military Personnel
Etiology of Community-Acquired Pneumonia in 139(1)
Other Subgroups of Patients
References 140(3)
Nursing Home-Acquired Pneumonia 143(20)
Andrew E. Simor
Introduction 143(1)
Epidemiology, Risk Factors, and Outcome 143(2)
Host Defenses and Pathogenesis 145(2)
Microbial Etiology 147(2)
Specific Pathogens 149(2)
Clinical Features 151(1)
Diagnosis 152(1)
Treatment 153(1)
Infection Control and Prevention 154(1)
Summary and Future Studies 155(1)
References 156(7)
Treatment of Community-Acquired Pneumonia 163(16)
Mark Woodhead
Introduction 163(1)
Is It Community-Acquired Pneumonia? 164(1)
Assessment of Illness Severity 165(2)
Where Should the Patient be Managed? 167(1)
Principles of Antimicrobial Therapy 167(3)
Guidelines for Empirical Oral, Intravenous, 170(5)
and Switch Therapy
Conclusions 175(1)
References 175(4)
Pathophysiology of Pneumonia and the Clinical 179(14)
Consequences
Ward Patrick
Introduction 179(1)
Routes of Bacterial Exposure 179(1)
Host Defenses of the Upper Airway 180(1)
Host Defenses of the Lower Airway 181(1)
Effect of Pneumonia on Lung Mechanics and 181(2)
Pulmonary Function Testing
Pathophysiology of Abnormal Gas Exchange in 183(2)
Pneumonia
Septic Shock Associated with Pneumonia 185(1)
Definitions from ACCP/SCCM Consensus 185(1)
Conference
Pathophysiology of Septic Shock at a 186(1)
Cellular Level
Clinical Presentation of Pneumonia with 187(2)
Septic Shock
References 189(4)
Intensive Care Unit Management of Pneumonia 193(12)
Thomas J. Nolan
David G. McCormack
Severe Community-Acquired Pneumonia 193(1)
Pathogens of Severe Community-Acquired 193(3)
Pneumonia
Diagnosis 196(1)
Treatment 196(3)
Complications of Severe Community-Acquired 199(3)
Pneumonia
Prognosis 202(1)
Summary 202(1)
References 203(2)
End-of-Life Decision-Making in 205(16)
Community-Acquired Pneumonia
Kenneth Rockwood
Colin Powell
Introduction 205(1)
An Approach to End-of-Life Decision-Making 205(8)
Providing Palliative Care 213(4)
Summary 217(1)
References 217(4)
Prevention of Community-Acquired Pneumonia: 221(18)
Influenza and Pneumococcal Vaccines
Jay C. Butler
Keiji Fukuda
Robert F. Breiman
Introduction 221(1)
Influenza Vaccines 222(5)
Pneumococcal Vaccines 227(6)
References 233(6)
Aspiration Pneumonia 239(18)
Marcio Sa-Borges
Jordi Rello
Introduction 239(1)
Classification 239(1)
Risk Factors and Prevention 240(2)
Aspiration of Fluid 242(2)
Aspiration of Solid Particles 244(2)
Aspiration of Pathogenic Bacteria 246(3)
Treatment 249(3)
Conclusions 252(1)
References 253(4)
Complicated Pleural Effusion in 257(16)
Community-Acquired Pneumonia
Richard W. Light
Definitions and Introduction 257(1)
History 257(1)
Natural History of Parapneumonic Effusions 258(1)
Classification of Parapneumonic Effusions 258(2)
Animal Studies of Empyema 260(3)
Clinical Manifestations 263(1)
Diagnosis 264(2)
Options for Treatment of Complicated 266(3)
Parapneumonic Effusions
Recommended Management of Parapneumonic 269(1)
Effusions
References 270(3)
A Critical Pathway for the Treatment of 273(10)
Community-Acquired Pneumonia
Thomas J. Marrie
Introduction 273(2)
Antibiotic Therapy 275(1)
Discharge Decision 276(1)
Prevention 276(1)
Critical Pathways 276(1)
Follow-up Chest Radiographs 277(1)
Pneumonia Complications 277(1)
Laboratory Investigation 277(1)
Physician Behavioral Change as a Result of 277(1)
Continuing Medical Education
Exclusion Criteria 278(1)
Implementation of the Pneumonia Critical 278(1)
Pathway
References 279(4)
Pneumonia in Pregnancy 283(10)
Joanne M. Langley
The Pregnant Woman as a Host: Respiratory 283(1)
and Immunologic Changes
Epidemiology of Pneumonia in Pregnancy 284(1)
Clinical Features 285(2)
Diagnosis 287(1)
Treatment 288(1)
References 289(4)
Pneumonia in Children and Adolescents 293(12)
Elaine Ee Ling Wang
Herbert Dele Davies
Epidemiology 293(1)
Etiologic A gents 293(1)
Clinical Findings 294(2)
Diagnosis 296(2)
Management 298(2)
Conclusions and Research Priorities 300(1)
References 300(5)
Pneumonia in HIV-Infected Patients 305(16)
Walter F. Schlech III
Introduction 305(1)
Immunologic Defects in HIV Infection 305(1)
The Changing Epidemiology of 306(2)
Community-Acquired Pneumonia in Patients
with HIV Infection
Pneumococcal Pneumonia in HIV-Positive 308(1)
Patients
Other Bacterial Pneumonias Associated with 309(3)
HIV Infection
Community-Acquired Viral Pneumonia in HIV 312(2)
Infection
Community-Acquired Fungal Infection in HIV 314(1)
Infected Patients
Approach to Pneumonia in HIV-Infected 315(2)
Patients
References 317(4)
Community-Acquired Pneumonia in the 321(16)
Immunocompromised Host
Robert H. Rubin
Jay A. Fishman
Risk of Pneumonia in the Immunocompromised 322(1)
Host
Clinical Clues to the Diagnosis of 323(1)
Pulmonary Infection in the
Immunocompromised Host
Radiologic Evaluation 324(1)
Timetable of Infection 325(1)
Noninfectious Causes of Pneumonia in 326(2)
Immunocompromised Patients
Infectious Causes of Pneumonia in the 328(4)
Immunocompromised Host
Diagnostic Approach to Pneumonia in the 332(1)
Immunocompromised Host
References 333(4)
Chronic Bacterial Pneumonia 337(14)
Steven H. Kirtland
Richard H. Winterbauer
Introduction 337(1)
History 337(1)
Definition 337(1)
Epidemiology 338(1)
Clinical Presentation 338(2)
Roentgenography 340(1)
Bronchoscopy 340(1)
Microbiology 341(4)
Treatment 345(1)
Clinical Approach 345(1)
Summary 346(1)
References 347(4)
Pneumonia Mimics 351(18)
Henry Su
Richard H. Winterbauer
Introduction 351(1)
Pulmonary Embolism 352(2)
Pulmonary Neoplasm 354(2)
Radiation Pneumonitis 356(1)
Bronchiolitis Obliterans Organizing 357(1)
Pneumonia
Collagen Vascular Disease 358(1)
Drug-Induced Pulmonary Disease 359(1)
Hypersensitivity Pneumonitis 360(2)
Granulomatous Vasculitis 362(1)
Churg-Strauss Syndrome 363(1)
Chronic Eosinophilic Pneumonia 364(1)
Summary 364(1)
References 365(4)
Lung Abscess 369(18)
Christopher W. H. Davies
Fergus V. Gleeson
Robert J. O. Davies
Introduction 369(1)
Epidemiology and Etiology 369(3)
Clinical Features 372(2)
Diagnostic Imaging 374(2)
Medical Therapy 376(5)
Interventional Therapy 381(2)
Complications 383(1)
Prognosis 383(1)
Summary 384(1)
References 384(3)
Nonresolving Pneumonia 387(28)
David Ost
Anna Rozenshtein
Alan Fein
Introduction 387(1)
Definitions 387(4)
Infectious Etiologies 391(6)
Noninfectious Etiologies 397(9)
Approach to Nonresolving Pneumonia 406(2)
Summary 408(1)
References 409(6)
Community-Acquired Pneumonia Associated with 415(12)
Exposure to Contaminated Water
Todd F. Hatchette
Introduction 415(1)
Aeromonas 416(1)
Chromobacterium violaceum 417(1)
Cyanobacteria 418(1)
Francisella philomiragia 418(1)
Leptospira 419(4)
Vibrio 423(1)
References 423(4)
Pneumococcal Pneumonia 427(28)
Ake Ortqvist
Introduction 427(1)
Microbiology 427(1)
Pathogenesis 428(2)
Epidemiology 430(7)
Clinical Features 437(4)
Microbiological Diagnosis 441(3)
Treatment 444(1)
Clinical Course, Complications, and 445(4)
Prognosis
References 449(6)
Haemophilus influenzae 455(20)
Larry J. Strausbaugh
Introduction 455(1)
Properties 455(2)
Epidemiology 457(5)
Clinical Features 462(4)
Diagnosis 466(3)
Treatment 469(1)
References 470(5)
Community-Acquired Pneumonia: Staphylococcus 475(12)
aureus
Santiago Ewig
Antoni Torres
Introduction 475(1)
Pathogenesis 475(1)
Incidence 475(2)
Risk Factors 477(1)
Outcome and Prognostic Factors 478(1)
Clinical Presentation 479(1)
Microbiological Diagnosis 479(1)
Antimicrobial Treatment 480(1)
Conclusions 481(1)
References 482(5)
Mycoplasma pneumoniae Pneumonia 487(14)
Thomas M. File, Jr.
James S. Tan
Microbiology and Pathogenesis 487(1)
Prevalence and Epidemiology 488(2)
Perspectives on the Classification of 490(1)
Atypical Pathogens
Clinical Characteristics 490(4)
Diagnosis 494(2)
Therapy 496(2)
References 498(3)
Community-Acquired Pneumonia Due to Chlamydia 501(10)
pneumoniae
Julio A. Ramirez
James T. Summersgill
Introduction 501(1)
Microbiology 501(1)
Pathogenesis 501(1)
Epidemiology 502(1)
Clinical and Laboratory Manifestations 503(1)
Radiographic Manifestations 503(1)
Extrapulmonary Manifestations 504(1)
Laboratory Diagnosis 504(2)
Antibiotic Therapy 506(1)
References 506(5)
Legionnaires' Disease 511(10)
Joseph F. Plouffe
Introduction 511(1)
Microbiology 511(1)
Antimicrobial Susceptibility 512(1)
Epidemiology 513(1)
Epidemics 513(1)
Clinical Manifestations 514(1)
Diagnosis 515(1)
Serologies 516(1)
Treatment 516(1)
Control 517(1)
Pontiac Fever 517(4)
References 521(1)
Community-Acquired Aerobic Gram-Negative 521(10)
Bacillary Pneumonia
James S. Tan
Introduction 521(1)
Incidence 521(1)
Klebsiella pneumoniae 522(2)
Escherichia coli 524(1)
Pseudomonas aeruginosa 524(1)
Acinetobacter species 525(1)
Aeromonas hydrophila and Other 525(1)
Gram-Negative Bacteria
Pneumonia plus Bacteremia 526(1)
Diagnosis 526(1)
Treatment 527(1)
Summary 527(1)
References 528(3)
Community-Acquired Pneumonia Due to 531(10)
Nonfermenting Gram-Negative Bacilli
Todd F. Hatchette
Introduction 531(1)
Pseudomonadaceae 531(4)
Acinetobacter 535(3)
References 538(3)
Miscellaneous Bacterial Causes of 541(30)
Community-Acquired Pneumonia
Todd F. Hatchette
Clostridium 541(12)
Eikenella 553(2)
Listeria 555(5)
Neisseria 560(5)
References 565(6)
Q Fever 571(22)
Thomas J. Marrie
Background 571(1)
Coxiella burnetti 572(2)
Epidemiology 574(1)
Coxiellosis in Laboratory Animals 574(1)
Domestic Animals 575(1)
Man 575(2)
Modes of Transmission of Q Fever to Man 577(1)
Clinical Manifestations of Q Fever 578(7)
Acute Q Fever Treatment 585(2)
Laboratory Diagnosis of Coxiella burnetti 587(1)
Infections
References 587(6)
Viral Pneumonia Due to Influenza and 593(24)
Parainfluenza Viruses and Adenoviruses
Thomas R. Cate
Influenza Viruses 593(9)
Parainfluenza Viruses 602(3)
Adenoviruses 605(4)
References 609(8)
Respiratory Syncytial Virus Pneumonia 617(12)
Ann R. Falsey
Introduction 617(1)
Organism 617(1)
Transmission 618(1)
Pathology 618(1)
Epidemiology 618(3)
Clinical Manifestations 621(2)
Diagnosis 623(1)
Treatment 624(1)
Prevention 625(1)
References 625(4)
Measles and Varicella Pneumonia 629(14)
B. Lynn Johnston
Measles Pneumonia: Case Presentation 629(1)
Measles 629(2)
Measles Pneumonia 631(4)
Varicella Pneumonia: Case Presentation 635(1)
Varicella 635(1)
Varicella Pneumonia 636(4)
References 640(3)
Hantavirus Pulmonary Syndrome 643(12)
Steven Q. Simpson
Introduction 643(1)
Hantaviruses 643(3)
Epidemiology 646(1)
Clinical Features 646(2)
Diagnosis 648(1)
Treatment 649(2)
Summary 651(1)
References 651(4)
Epstein-Barr Virus Pneumonia 655(10)
Masis Perk
Thomas J. Marrie
Introduction 655(1)
Case 1 655(1)
Case 2 656(2)
Case 3 658(2)
Discussion 660(3)
Conclusion 663(1)
References 663(2)
Community-Acquired Pneumonia Due to 665(14)
Cytomegalovirus, Herpes Simplex 1 Virus, and
Human Herpesvirus-6
Kevin Forward
Introduction 665(1)
The Herpesviridae 665(1)
Human Cytomegalovirus Pneumonia 666(3)
Human Herpesvirus-6 Pneumonia 669(2)
Herpes Simplex Pneumonia 671(3)
References 674(5)
Community-Acquired Fungal Diseases 679(30)
George A. Sarosi
Scott F. Davies
Histoplasma capsulatum 680(9)
Blastomycosis 689(6)
Coccidioidomycosis 695(7)
Cryptococcal Pneumonia 702(3)
References 705(4)
Penicillium and Other Miscellaneous Fungi as 709(12)
Causal Agents in Community-Acquired Pneumonia
Todd F. Hatchette
Introduction 709(1)
Phaeohyphomycosis 709(1)
Zygomycetes 710(1)
Yeasts 711(1)
Hyalohyphomycosis 712(5)
References 717(4)
Aspergillus Species as Agents of 721(10)
Community-Acquired Pneumonia
Thomas J. Marrie
Introduction 721(1)
The Organism 721(1)
Pathogenesis 721(1)
Definition of Invasive Aspergillosis 722(2)
Acute Community-Acquired Pneumonia Due to 724(1)
Aspergillus in Immunocompetent Hosts
Invasive Pulmonary Aspergillosis in 724(1)
Patients with Chronic Obstructive Pulmonary
Disease
Invasive Aspergillosis in Patients with HIV 724(1)
Infection
Invasive Aspergillosis in the 725(1)
Immunocompromised Host
Chronic Necrotizing Pulmonary Aspergillosis 726(1)
Diagnosis 726(1)
Treatment 727(1)
References 728(3)
Pneumocystis carinii Pneumonia 731(12)
Valentina Carla Montessori
Julio S. G. Montaner
Introduction 731(1)
Epidemiology 731(1)
Clinical Features 732(1)
Microbiological Diagnosis 732(4)
Prognosis 736(1)
Treatment 736(2)
Prophylaxis 738(1)
Conclusion 738(1)
References 739(4)
Group B Streptococcal and Other 743(8)
Nonpneumococcal Streptococcal Pneumonia
Steven Berk
James W. Myers
Introduction 743(1)
Group B Beta-Hemolytic Streptococcal 743(1)
Pneumonia
Group C Streptococci 744(1)
Group G Streptococci 745(1)
Enterococcal Pneumonia 746(1)
Streptococcus pyogenes 746(1)
Streptococcus Intermedius Group 747(1)
References 747(4)
Mycobacterium tuberculosis as a Cause of 751(26)
Community-Acquired Pneumonia
Dick Menzies
Introduction 751(1)
Bacteriology of Tuberculosis 751(1)
Transmission 752(1)
Pathogenesis 753(1)
Reactivation 754(1)
Epidemiology 755(1)
Clinical Features 756(1)
Laboratory Diagnosis 757(1)
Accuracy and Reliability of the Chest X-Ray 758(2)
Microbiologic Tests 760(2)
Other Tests 762(6)
Tuberculosis Treatment 768(4)
References 772(5)
Pneumonia Caused by Yersinia pestis: Plague 777(24)
Pneumonia
Dennis James Cleri
Randy Marton
Mohamed Rabbat
John Vernaleo
Introduction 777(1)
History 778(4)
Microbiology 782(4)
Pathogenesis 786(1)
Epidemiology 787(1)
Clinical Presentations 788(5)
Treatment 793(2)
Summary and Conclusions 795(1)
References 795(6)
Nontuberculous Mycobacteria 801(10)
Stephen D. Shafran
Introduction 810
Pulmonary Disease 802(1)
Criteria for Nontuberculous Mycobacterial 802(1)
Pulmonary Disease
Disease Due to Specific Nontuberculous 802(6)
Mycobacteria Species
References 808(3)
Melioidosis 811(10)
Stephen A. Berger
Introduction 811(1)
Epidemiology 811(1)
Pathogenesis 812(1)
Clinical Presentation 812(1)
Roentgenographic Findings 813(1)
Differential Diagnosis 813(1)
Bacteriology and Laboratory Diagnosis 814(1)
Therapy 815(1)
Prognosis 816(1)
References 816(5)
Pneumonia Due to Nocardia Species 821(6)
Thomas J. Marrie
Introduction 821(1)
Case 1 821(1)
Case 2 822(1)
Case 3 822(1)
The Organism 822(1)
Epidemiology 823(1)
Clinical Manifestations 823(1)
Treatment 824(1)
References 824(3)
Actinomycosis 827(14)
David J. M. Haldane
Introduction 820
Epidemiology 280(550)
Clinical Features 830(1)
Endobronchial Actinomycosis 830(1)
Actinomycosis and HIV 831(1)
Disseminated Actinomycosis 832(1)
Pathology 832(4)
Diagnosis
Treatment 836(3)
References 839(2)
Tularemia 841(8)
Burke A. Cunha
Diane H. Johnson
Introduction 841(1)
Epidemiology 841(1)
Microbiology 842(1)
Clinical Manifestations 842(2)
Diagnosis 844(1)
Treatment 844(2)
References 846(3)
Psittacosis 849(6)
Burke A. Cunha
Natalie C. Klein
Introduction 849(1)
Epidemiology 849(1)
Microbiology 850(1)
Clinical Manifestations 850(1)
Diagnosis 851(1)
Treatment 852(1)
References 852(3)
Moraxella (Branhamella) catarrhalis 855(20)
Dick Zoutman
Introduction and Taxonomy 855(1)
Moraxella catarrhalis Colonization of the 855(1)
Respiratory Tract in Health and Disease
The Outer Membrane Proteins and Pili of 856(3)
Moraxella catarrhalis
Immune Response to Surface Antigens of 859(1)
Moraxella catarrhalis
Lower Respiratory Infections Caused by 860(2)
Moraxella catarrhalis
Microbiology Laboratory Identification and 862(1)
Susceptibility Testing of Moraxella
catarrhalis
Antimicrobial Susceptibility and Therapy 863(3)
References 866(9)
Pasteurella multocida 875(2)
Thomas J. Marrie
Introduction 875(1)
Pneumonia 875(1)
Treatment 876(1)
References 876(1)
Rhodococcus equi and Bordetella bronchiseptica 877(8)
Claire Touchie
Rhodococcus equi 877(3)
Bordetella bronchiseptica 880(2)
References 882(3)
Parasites 885(22)
Kathryn N. Suh
Jay S. Keystone
Introduction 885(1)
Tropical Lung Disease 885(4)
Selected Parasitic Pulmonary Diseases 889(13)
References 902(5)
Index 907